- Home
- SYTA vs PRFX Comparison
SYTA vs PRFX Comparison
Compare SYTA & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYTA
- PRFX
- Stock Information
- Founded
- SYTA 1986
- PRFX 2007
- Country
- SYTA Canada
- PRFX Israel
- Employees
- SYTA N/A
- PRFX N/A
- Industry
- SYTA Telecommunications Equipment
- PRFX Biotechnology: Pharmaceutical Preparations
- Sector
- SYTA Telecommunications
- PRFX Health Care
- Exchange
- SYTA Nasdaq
- PRFX Nasdaq
- Market Cap
- SYTA 3.1M
- PRFX 3.0M
- IPO Year
- SYTA 2020
- PRFX 2020
- Fundamental
- Price
- SYTA $2.08
- PRFX $2.19
- Analyst Decision
- SYTA
- PRFX Hold
- Analyst Count
- SYTA 0
- PRFX 1
- Target Price
- SYTA N/A
- PRFX N/A
- AVG Volume (30 Days)
- SYTA 736.2K
- PRFX 33.0K
- Earning Date
- SYTA 05-15-2025
- PRFX 01-01-0001
- Dividend Yield
- SYTA N/A
- PRFX N/A
- EPS Growth
- SYTA N/A
- PRFX N/A
- EPS
- SYTA N/A
- PRFX N/A
- Revenue
- SYTA $11,629,572.00
- PRFX N/A
- Revenue This Year
- SYTA $75.92
- PRFX N/A
- Revenue Next Year
- SYTA $19.72
- PRFX N/A
- P/E Ratio
- SYTA N/A
- PRFX N/A
- Revenue Growth
- SYTA 41.59
- PRFX N/A
- 52 Week Low
- SYTA $1.82
- PRFX $0.43
- 52 Week High
- SYTA $885.60
- PRFX $16.63
- Technical
- Relative Strength Index (RSI)
- SYTA 40.18
- PRFX 33.59
- Support Level
- SYTA $1.88
- PRFX $2.12
- Resistance Level
- SYTA $2.48
- PRFX $2.30
- Average True Range (ATR)
- SYTA 0.33
- PRFX 0.15
- MACD
- SYTA 0.11
- PRFX -0.04
- Stochastic Oscillator
- SYTA 11.17
- PRFX 8.75
About SYTA Siyata Mobile Inc.
Siyata Mobile Inc is engaged in the sale of vehicle mounted, cellular-based communications platforms over advanced 3G (Third generation) mobile networks and cellular booster systems. The Company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (PoC) smartphone devices. These rugged business-to-business (B2B) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries. The company operates in USA, Canada, EMEA and Australia. It derives maximum revenue from USA.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.